PetMed Express, Inc.
NMS: PETSLive Quote
📈 ZcoreAI Score
Our AI model analyzes PetMed Express, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get PETS Z-Score →About PetMed Express, Inc.
Healthcare
Pharmaceutical Retailers
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
📊 Fundamental Analysis
PetMed Express, Inc. demonstrates a profit margin of -34.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported -21.7% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -100.6%, which indicates that capital utilization is currently under pressure.
At a current price of $2.30, PETS currently sits at the 27th percentile of its 52-week range (Range: $1.57 - $4.32).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$49.22M
Trailing P/E
--
Forward P/E
-76.67
Beta (5Y)
0.78
52W High
$4.32
52W Low
$1.57
Avg Volume
120K
Day High
Day Low